Cellino develops an AI-driven, automated biomanufacturing platform for producing personalized regenerative cell therapies from patients’ own cells
Cellino develops an AI-driven, automated biomanufacturing platform for producing personalized regenerative cell therapies from patients’ own cells. Its modular Nebula system combines deep learning, image-guided optical processing, laser-based cell management, and scalable cassette-based manufacturing to support production of iPSC-derived treatments for degenerative diseases.